These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27839583)

  • 1. Spatial variations in cervical cancer prevention in Colombia: Geographical differences and associated socio-demographic factors.
    Bermedo-Carrasco S; Waldner C; Peña-Sánchez JN; Szafron M
    Spat Spatiotemporal Epidemiol; 2016 Nov; 19():78-90. PubMed ID: 27839583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervical cancer screening and updated Pap guidelines.
    Warren JB; Gullett H; King VJ
    Prim Care; 2009 Mar; 36(1):131-49, ix. PubMed ID: 19231606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Following-up females having an abnormal Pap smear in Colombia].
    Wiesner C; Cendales R; Murillo R; Piñeros M; Tovar S
    Rev Salud Publica (Bogota); 2010 Feb; 12(1):1-13. PubMed ID: 20628695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inequities in cervical cancer screening among Colombian women: a multilevel analysis of a nationwide survey.
    Bermedo-Carrasco S; Peña-Sánchez JN; Lepnurm R; Szafron M; Waldner C
    Cancer Epidemiol; 2015 Apr; 39(2):229-36. PubMed ID: 25707752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of health care coverage in cervical cancer screening follow-up: findings from a cross-sectional study in Colombia.
    Garcés-Palacio IC; Altarac M; Kirby R; McClure LA; Mulvihill B; Scarinci IC
    Int J Gynecol Cancer; 2010 Oct; 20(7):1232-9. PubMed ID: 21495237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experiences and unmet needs of women undergoing Pap smear cervical cancer screening: impact on uptake of cervical cancer screening in south eastern Nigeria.
    Chigbu CO; Onyebuchi AK; Egbuji CC; Ezugwu EC
    J Cancer Educ; 2015 Mar; 30(1):81-5. PubMed ID: 24980966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of having heard about human papillomavirus vaccination: Critical aspects for cervical cancer prevention among Colombian women.
    Bermedo-Carrasco S; Feng CX; Peña-Sánchez JN; Lepnurm R
    Gac Sanit; 2015; 29(2):112-7. PubMed ID: 25444387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
    Touch S; Oh JK
    BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of socio-demographic factors in premature cervical cancer mortality in Colombia.
    Bermedo-Carrasco S; Waldner CL
    BMC Public Health; 2016 Sep; 16():981. PubMed ID: 27628314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
    Song T; Seong SJ; Lee SK; Kim BR; Ju W; Kim KH; Nam K; Sim JC; Kim TJ
    J Obstet Gynaecol; 2020 Feb; 40(2):240-246. PubMed ID: 31340702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
    Johnson NL; Head KJ; Scott SF; Zimet GD
    Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic human papillomavirus infection and cervical lesions in aboriginal women of Nunavut, Canada.
    Healey SM; Aronson KJ; Mao Y; Schlecht NF; Mery LS; Ferenczy A; Franco EL
    Sex Transm Dis; 2001 Dec; 28(12):694-700. PubMed ID: 11725224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human Papilloma Virus (HPV), cervical cancer incidence and screening uptake: differences among Northern, Central and Southern Italy].
    Giorgi Rossi P; Chini F; Borgia P; Guasticchi G; Carozzi FM; Confortini M; Angeloni C; Buzzoni C; Buonaguro FM;
    Epidemiol Prev; 2012; 36(2):108-19. PubMed ID: 22706361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africa
    Rohner E; Mulongo M; Pasipamire T; Oberlin AM; Goeieman B; Williams S; Lubeya MK; Rahangdale L; Chibwesha CJ
    Int J Gynaecol Obstet; 2021 Jan; 152(1):53-59. PubMed ID: 33188707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States.
    Hosier H; Sheth SS; Oliveira CR; Perley LE; Vash-Margita A
    Am J Obstet Gynecol; 2021 Dec; 225(6):649.e1-649.e9. PubMed ID: 34256029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of risk factors and human papillomavirus (HPV) related pathogenetic mechanisms of CIN in HIV-positive and HIV-negative women. Study design and baseline data of the HPV-PathogenISS study.
    Branca M; Costa S; Mariani L; Sesti F; Agarossi A; di Carlo A; Galati M; Benedetto A; Ciotti M; Giorgi C; Criscuolo A; Valieri M; Favalli C; Paba P; Santini D; Piccione E; Alderisio M; De Nuzzo M; di Bonito L; Syrjänen K
    Eur J Gynaecol Oncol; 2004; 25(6):689-98. PubMed ID: 15597844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancers attributable to human papillomavirus infection.
    Grulich AE; Jin F; Conway EL; Stein AN; Hocking J
    Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale and design of a multicenter prospective cohort study for the eVALuation and monitoring of HPV infections and relATEd cervical diseases in high-risk women (VALHIDATE study).
    Orlando G; Tanzi E; Chatenoud L; Gramegna M; Rizzardini G;
    BMC Cancer; 2012 May; 12():204. PubMed ID: 22646512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.